Home > Balance Sheet > BIOCON

BIOCON
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹74 Cr₹81 Cr₹-241 Cr₹-275 Cr₹-338 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of BIOCON ?

The latest Deferred Tax Assets / Liabilities ratio of BIOCON is ₹74 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹74 Cr
Mar2023₹81 Cr
Mar2022₹-241 Cr
Mar2021₹-275 Cr
Mar2020₹-338 Cr

How is Deferred Tax Assets / Liabilities of BIOCON Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹74 Cr
-8.17
Mar2023 ₹81 Cr
Positive
Mar2022 ₹-241 Cr
Negative
Mar2021 ₹-275 Cr
Negative
Mar2020 ₹-338 Cr -

Compare Deferred Tax Assets / Liabilities of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹41,882.9 Cr -7.5% -11.2% 32.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,003.0 Cr -1.6% -4.6% 14.7% Stock Analytics
DIVIS LABORATORIES ₹154,939.0 Cr -1.6% -1.3% 61.6% Stock Analytics
CIPLA ₹117,835.0 Cr 0.1% 1.2% 3.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,787.0 Cr -2.1% -8.7% -2.3% Stock Analytics
ZYDUS LIFESCIENCES ₹90,722.1 Cr -6.5% -9.3% 8.6% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-7.5%

-11.2%

32.3%

SENSEX

-2.5%

-1.4%

6.1%


You may also like the below Video Courses